Jarislowsky, Fraser LTD Organon & Co. Transaction History

Jarislowsky, Fraser LTD

  • $16.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$28.67 - $37.13 $260,696 - $337,623
-9,093 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$28.63 - $35.64 $33,325 - $41,484
-1,164 Reduced 11.35%
9,093 $298,000
Q2 2021

Aug 09, 2021
BUY
$28.45 - $38.0 $291,811 - $389,766
10,257 New
10,257 $310,000

Others Institutions Holding OGN

# of Institutions
794
Shares Held
193M
Call Options Held
1.71M
Put Options Held
865K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.11B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Jarislowsky, Fraser LTD Portfolio

Follow Jarislowsky, Fraser LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email